Roche’s Alzheimer antibody granted U.S. FDA Breakthrough Therapy Designation
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
The company plans to expand its portfolio in regulated markets aggressively
A total of 8308 stores are open across India and medicines are priced at affordable rates
A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects
This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines
More than 90,000 patients utilise the services daily
The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge
Lilly will continue to maintain its existing operating model for the remaining portfolio of products
Torrent is one of India's fastest-growing pharma majors
Subscribe To Our Newsletter & Stay Updated